Evaluation of HBsAg and Anti‐HBs Coexistence: Authenticity and Contributing Factors
Journal of Medical Virology · 2026-03 · 98 (3)
DOI: 10.1002/jmv.70862 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 06.03.2026. Verfasst von Hao Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B Antibodies, Hepatitis B, Coinfection. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Industry-University Cooperation Collaborative Education Project of the Ministry of Education, Wu Jieping Medical Foundation Special Clinical Research Fund.
Abstract (Originalsprache)
The coexistence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti‐HBs) is an uncommon but clinically important serological pattern, with a reported prevalence ranging from 2.8% to 35.95%. This study aimed to evaluate the authenticity of this coexistence pattern and to investigate its underlying causes. A total of 300 sera co‐positive for HBsAg and anti‐HBs were incubated with recombinant HBsAg (rHBsAg) of the adw, adr, and ayw serotypes, as well as with pooled clinical HBsAg‐positive sera, to calculate the neutralization index (NI) of anti‐HBs. In parallel, the same co‐positive samples were incubated with pooled clinical anti‐HBs–positive sera to determine the NI of HBsAg. Additionally, 180 sera from healthy individuals under 32 years of age with isolated anti‐HBs positivity were tested against adw and adr rHBsAg and pooled clinical HBsAg‐positive sera to establish neutralization thresholds. Among the 300 co‐positive samples, HBsAg was confirmed positive in 100%, and anti‐HBs was confirmed positive in 89.00% (267/300). The prevalence of true coexistence decreased with increasing anti‐HBs concentrations: 91.55% in the 10.00–50.00 mIU/mL group, 86.11% in the 50.00–100.00 mIU/mL group, and 76.92% in the > 100.00 mIU/mL group ( p = 0.025). In serotype analysis, 46.82% (125/267) of anti‐HBs were neutralized by adw and adr rHBsAg but not by ayw rHBsAg. Another 49.44% (132/267) could not be neutralized by any of the three rHBsAg preparations but were neutralized by pooled clinical sera. The proportion of truly anti‐HBs positive individuals was relatively high among co‐positive samples, and this proportion increased as anti‐HBs concentrations decreased. The coexistence of HBsAg and anti‐HBs may be attributed to coinfection with both ayr and common serotypes, or to post‐vaccination infection with ayw or ayr serotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
- Department of Laboratory Medicine, North Sichuan Medical College, Nanchong, Sichuan, China.
- Translational Medicine Research Center, North Sichuan Medical College, Nanchong, Sichuan, China.
- Department of Laboratory Medicine, The Sixth People's Hospital of Yibin, Yibin, Sichuan, China.
ORCID-Profile: Hao Xu
Förderung
- Industry-University Cooperation Collaborative Education Project of the Ministry of Education
- Wu Jieping Medical Foundation Special Clinical Research Fund
Zitieren
APA
Xu, H., Yang, X., Chen, L., Yao, X., Xu, Y., & Wang, Q. (2026). Evaluation of HBsAg and Anti‐HBs Coexistence: Authenticity and Contributing Factors. Journal of Medical Virology, 98(3). https://doi.org/10.1002/jmv.70862
Vancouver
Xu H, Yang X, Chen L, Yao X, Xu Y, Wang Q. Evaluation of HBsAg and Anti‐HBs Coexistence: Authenticity and Contributing Factors. Journal of Medical Virology. 2026;98(3). doi:10.1002/jmv.70862
BibTeX
@article{Xu2026,
author = {Xu, Hao and Yang, Xingyong and Chen, Liuyang and Yao, Xiaoqin and Xu, Yuan and Wang, Qiang},
title = {Evaluation of HBsAg and Anti‐HBs Coexistence: Authenticity and Contributing Factors},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {3},
doi = {10.1002/jmv.70862}
}
EUVIMED